Agenda Stem Cells – Liste



  • Hydra XII - The European Summer School on Stem Cell & Regenerative Medicine

    11/09/2017 - 18/09/2017
    Hydra, Greece

    The leading European Summer School on Stem Cell Biology
    This summer school will provide a critical analysis of contemporary issues in stem cell biology. During the in-depth, week-long programme, participants will attend lectures and workshops on

    The biology of stem cells - embryonic, fetal and adult systems
    Plasticity, epigenetic regulation, signaling and niche
    Clinical applications and clinical trials
    Ethics and patents in stem cell research


  • IFORUM 2016 Disease Modeling & Reg Med

    ICM Institut du Cerveau et de la Moelle épinière, ICM, Hôpital Pitié Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France

    Organized by Cellualr Dynamics Int.

    Marc Peschanski, PhD, Scientific Director, I-Stem Institute
    Harnessing Human Pluripotent Stem Cells for Pharmacology
    Benjamin Morlon, PhD, Manager of Business Development, ICM – Brain & Spine Institute
    An Introduction to ICM, The Brain & Spine Institute
    Claus Rieker, PhD, Brain Health Specialist, Brain Health Platform, Nestlé Institute of Health Sciences
    Alzheimer’s Disease and APOE4
    Georg Rast, PhD, Principal Scientist, Boehringer Ingelheim Pharma
    Relationship of Field Potential, Duration and Spontaneous Rate in hiPSC-derived Cardiomyocytes
    Dries Braeken, PhD, Research & Development Team Leader. Life Science Technologies Department, IMEC
    Advanced Electrophysiology Silicon Technologies for Cell-based Applications
    Camille Nicoleau, PhD, Principal Scientist, In Vitro Toxin Group Global Drug Discovery, Ipsen Innovation
    The Potential of Using Human Induced Pluripotent Stem Cells for the Study of Botulinum Neurotoxins
    Jean Philippe Stephan, PhD, Department Head, HTS Department Biotechnology, Servier
    New Generation Phenotypic Screens: The Missing Link!
    Ángel Raya, MD, PhD, Professor, Center of Regenerative Medicine CMR Barcelona
    Opportunities of iPS Cell Technology for Modeling Neurodegenerative Diseases
    Andreas Mühlemann, PhD, Senior Lab Head, CNS Biology, Actelion Pharmaceuticals Ltd
    Characterization and Implementation of iPSC-derived Neurons in Phenotypic Drug Discovery
    Amy Pointon, PhD, Associate Principal Scientist, Drug Safety and Metabolism, AstraZeneca
    Use of Stem Cell-derived Cardiomyocyte 2D and 3D Models for the Detection of Cardiotoxicity
    Remco Westerink, PhD, Head, Neurotoxicology Research Group at the Institute for Risk Assessment Sciences (IRAS), Utrecht University
    Using Human iPSC-derived Neurons for Functional Neurotoxicity Testing in Vitro

    Institut du Cerveau et de la Moelle Epinière
    Hôpital Pitié Salpêtrière
    47 Boulevard Hôpital
    75013 Paris, France